Journal of Thrombosis and Haemostasis, 1538-7933

Journal

More filtering options
  1. Prophylaxis Escalation in Severe von Willebrand Disease: A Prospective Study from the von Willebrand Disease Prophylaxis Network.

    Abshire, T., Cox-Gill, J., Kempton, C. L., Leebeek, F. W. G., Carcao, M., Kouides, P., Donfield, S. & Erik Berntorp, 2015, In : Journal of Thrombosis and Haemostasis. 13, 9, p. 1585-1589

    Research output: Contribution to journalArticle

  2. Recombinant human factor VIIa (rFVIIa) cleared principally by antithrombin following IV administration in haemophilia patients.

    Agersø, H., Brophy, D. F., Pelzer, H., Martin, E. J., Carr, M., Hedner, U. & Ezban, M., 2011, In : Journal of Thrombosis and Haemostasis. 9, 2, p. 333-338

    Research output: Contribution to journalArticle

  3. Anti-factor V auto-antibody in the plasma and platelets of a patient with repeated gastrointestinal bleeding

    Ajzner, E., Balogh, I., Haramura, G., Boda, Z., Kalmar, K., Pfliegler, G., Björn Dahlbäck & Muszbek, L., 2003, In : Journal of Thrombosis and Haemostasis. 1, 5, p. 943-949

    Research output: Contribution to journalArticle

  4. Are randomized clinical trials the only truth? Not always

    Aledort, L., Rolf Ljung & Blanchette, V., 2006, In : Journal of Thrombosis and Haemostasis. 4, 3, p. 503-504

    Research output: Contribution to journalDebate/Note/Editorial

  5. Polymorphisms in the CTLA-4 gene and inhibitor development in patients with severe hemophilia A

    Jan Astermark, Wang, X., Oldenburg, J., Erik Berntorp & Lefvert, A. -K., 2007, In : Journal of Thrombosis and Haemostasis. 5, 2, p. 263-265

    Research output: Contribution to journalArticle

  6. The von Willebrand disease prophylaxis network: exploring a treatment concept.

    Erik Berntorp & Abshire, T., 2006, In : Journal of Thrombosis and Haemostasis. 4, 11, p. 2511-2512

    Research output: Contribution to journalArticle

  7. Definitions in hemophilia: communication from the SSC of the ISTH

    Blanchette, V. S., Key, N. S., Rolf Ljung, Manco-Johnson, M. J., Van Den Berg, H. M. & Srivastava, A., 2014, In : Journal of Thrombosis and Haemostasis. 12, 11, p. 1935-1939

    Research output: Contribution to journalArticle

  8. Treatment of severe von Willebrand disease with a high-purity von Willebrand factor concentrate (Wilfactin (R)): a prospective study of 50 patients

    Borel-Derlon, A., Federici, A. B., Roussel-Robert, V., Goudemand, J., Lee, C. A., Scharrer, I., Rothschild, C., Erik Berntorp, Henriet, C., Tellier, Z., Bridey, F. & Mannucci, P. M., 2007, In : Journal of Thrombosis and Haemostasis. 5, 6, p. 1115-1124

    Research output: Contribution to journalArticle

  9. Measuring factor IX activity of nonacog beta pegol with commercially available one-stage clotting and chromogenic assay kits: A two-center study

    Bowyer, A. E., A. Hillarp, Ezban, M., Persson, P. & Kitchen, S., 2016, In : Journal of Thrombosis and Haemostasis. 14, 7, p. 1428-1435

    Research output: Contribution to journalArticle

  10. Population Pharmacokinetics of Plasma-Derived Factor IX: Procedures for Dose Individualization.

    Brekkan, A., Erik Berntorp, Jensen, K., Nielsen, E. I. & Jönsson, S., 2016, In : Journal of Thrombosis and Haemostasis. 14, 4, p. 724-732

    Research output: Contribution to journalArticle

  11. Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD)

    Budde, U., Schneppenheim, R., Eikenboom, J., Goodeve, A., Will, K., Drewke, E., Castaman, G., Rodeghiero, F., Federici, A. B., Batlle, J., Perez, A., Meyer, D., Mazurier, C., Goudemand, J., Ingerslev, J., Habart, D., Vorlova, Z., Holmberg, L., Lethagen, S., Pasi, J. & 2 others, Hill, F. & Peake, I., 2008, In : Journal of Thrombosis and Haemostasis. 6, 5, p. 762-771

    Research output: Contribution to journalArticle

  12. Hemorrhagic symptoms and bleeding risk in obligatory carriers of type 3 von Willebrand disease: an international, multicenter study

    Castaman, G., Rodeghiero, F., Tosetto, A., Cappelletti, A., Baudo, F., Eikenboom, J. C. J., Federici, A. B., Lethagen, S., Linari, S., Lusher, J., Nishino, M., Petrini, P., Srivastava, A. & Ungerstedt, J. S., 2006, In : Journal of Thrombosis and Haemostasis. 4, 10, p. 2164-2169

    Research output: Contribution to journalArticle

  13. Endothelial cell protein C receptor-mediated redistribution and tissue-level accumulation of factor VIIa.

    Clark, C. A., Vatsyayan, R., Hedner, U., Esmon, C. T., Pendurthi, U. R. & Rao, L. V. M., 2012, In : Journal of Thrombosis and Haemostasis. 10, 11, p. 2383-2391

    Research output: Contribution to journalArticle

  14. Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A

    Collins, P. W., Blanchette, V. S., Fischer, K., Bjorkman, S., Oh, M., Fritsch, S., Schroth, P., Spotts, G., Jan Astermark & Ewenstein, B., 2009, In : Journal of Thrombosis and Haemostasis. 7, 3, p. 413-420

    Research output: Contribution to journalArticle

  15. Population pharmacokinetic modeling for dose setting of nonacog beta pegol (N9-GP), a glycoPEGylated recombinant factor IX.

    Collins, P. W., Møss, J., Knobe, K., Groth, A., Colberg, T. & Watson, E., 2012, In : Journal of Thrombosis and Haemostasis. 10, 11, p. 2305-2312

    Research output: Contribution to journalArticle

  16. The discovery of activated protein C resistance.

    Björn Dahlbäck, 2003, In : Journal of Thrombosis and Haemostasis. 1, 1, p. 3-9

    Research output: Contribution to journalArticle

  17. Molecular recognition in the protein C anticoagulant pathway.

    Björn Dahlbäck & Villoutreix, B. O., 2003, In : Journal of Thrombosis and Haemostasis. 1, 7, p. 1525-1534

    Research output: Contribution to journalArticle

  18. The multiple faces of the partial thromboplastin time APTT.

    Björn Dahlbäck, 2004, In : Journal of Thrombosis and Haemostasis. 2, 12, p. 2256-2257

    Research output: Contribution to journalLetter

  19. The Fc gamma receptor IIa R131H polymorphism is associated with inhibitor development in severe hemophilia A

    Eckhardt, C. L., Jan Astermark, Nagelkerke, S. Q., Geissler, J., Tanck, M. W. T., Peters, M., Fijnvandraat, K. & Kuijpers, T. W., 2014, In : Journal of Thrombosis and Haemostasis. 12, 8, p. 1294-1301

    Research output: Contribution to journalArticle

  20. Guidelines on preparation, certification, and use of certified plasmas for ISI calibration and INR determination - a rebuttal

    Egberg, N., Fagerberg, I., Andreas Hillarp, Lindahl, TL. & Stigendal, L., 2005, In : Journal of Thrombosis and Haemostasis. 3, 10, p. 2370-2371

    Research output: Contribution to journalLetter

  21. Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD

    Eikenboom, J., Van Marion, V., Putter, H., Goodeve, A., Rodeghiero, F., Castaman, G., Federici, AB., Batlle, J., Meyer, D., Mazurier, C., Goudemand, J., Schneppenheim, R., Budde, U., Ingerslev, J., Vorlova, Z., Habart, D., Holmberg, L., Lethagen, S., Pasi, J., Hill, F. & 1 others, Peake, I., 2006, In : Journal of Thrombosis and Haemostasis. 4, 4, p. 774-782

    Research output: Contribution to journalArticle

  22. Gas6 is complexed to soluble tyrosine kinase receptor Axl in human blood.

    Carl Ekman, Stenhoff, J. & Björn Dahlbäck, 2010, In : Journal of Thrombosis and Haemostasis. 8, 4, p. 838-844

    Research output: Contribution to journalArticle

Previous 1 2 3 4 5 Next